AI Bias Analysis
4 models · Takes ~15 seconds
Eli Lilly's deal with Profluent, Erasca's RAS-targeting cancer pill, and more biotech news today
Source
Stat News
Opens original article in a new tab
(MedPage Today) -- As "free birth" and low-intervention pregnancies remain an attractive option to some, a recent episode of "The Pitt" highlighted what can happen when routine prenatal monitoring is absent. In this MedPage Today video, Nikki...
(MedPage Today) -- Note that some links may require registration or subscription. Scientists are researching what role the gut's microbiome may have in the recent rise in colorectal cancer among young adults. (NPR) Rep. Thomas Kean, Jr. (R-N...
In this edition of STAT Health Tech newsletter: a conversation with Google's clinical director, an update on Doctronic's Utah experiment, and more.
The Novartis CEO warned that Trump's drug pricing policy poses a “very difficult situation” and the reality will soon catch up with drugmakers and patients
